Toggle SummaryMay 4, 2020
|
GenMark Diagnostics Announces Scott Mendel Appointed CEO
CARLSBAD, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that Scott Mendel has been appointed President and Chief Executive Officer effective immediately.
|
View HTML
|
Toggle SummaryApril 22, 2020
|
GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020
CARLSBAD, Calif. , April 22, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close on Monday, May 4, 2020. Management will hold a conference call to review the company's financial performance
|
View HTML
|
Toggle SummaryApril 7, 2020
|
GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance
First Quarter 2020 Revenue Expected to Represent Approximately 80% Year-Over-Year Growth CARLSBAD, Calif. , April 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary
|
View HTML
|
Toggle SummaryMarch 23, 2020
|
GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel
CARLSBAD, Calif. , March 23, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has been awarded a grant from the Biomedical Advanced Research and Development Authority (BARDA), part
|
View HTML
|
Toggle SummaryMarch 19, 2020
|
GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
COVID-19 diagnosis in under two hours now available globally in hospitals on company’s ePlex System Unique sample-to-answer capability enables near patient testing for the most critical patient populations CARLSBAD, Calif. , March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc.
|
View HTML
|
Toggle SummaryMarch 11, 2020
|
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
CARLSBAD, Calif. , March 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced submission for an Emergency Use Authorization (EUA) to the U.S.
|
View HTML
|
Toggle SummaryMarch 2, 2020
|
GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results
CARLSBAD, Calif. , March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ended December 31, 2019 .
|
View HTML
|
Toggle SummaryMarch 2, 2020
|
GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection
CARLSBAD, Calif. , March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the initial shipments of ePlex Research Use Only (RUO) test kits designed to detect the SARS-CoV-2 virus.
|
View HTML
|
Toggle SummaryFebruary 18, 2020
|
GenMark Diagnostics to Participate in the Cowen Health Care Conference
CARLSBAD, Calif. , Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen Health Care Conference in Boston, Massachusetts
|
View HTML
|
Toggle SummaryFebruary 10, 2020
|
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020
CARLSBAD, Calif. , Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market close on Monday, March 2, 2020. Management will hold a conference call to review the company's
|
View HTML
|